Recent News

• 12.05.2025 - Hyaluronic Acid-Coated Magnetic Nanoparticles: A Platform for Targeted Gemcitabine Delivery
• 11.06.2025 - Harvard Bioscience Announces Third Quarter 2025 Financial Results
• 10.30.2025 - Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
• 10.16.2025 - Modeling Prion Disease and Neural Connectivity Using Mesh MEA
• 09.18.2025 - Vascularized Cardiac and Hepatic Organoids: A Leap Forward for Organoid Electrophysiology
• 09.16.2025 - Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
• 09.16.2025 - Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
• 09.16.2025 - Harvard Bioscience Expands Distribution Agreement with Fisher Scientific to Include United States
• 09.09.2025 - Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors
• 09.09.2025 - Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors

Recent Filings

• 12.05.2025 - 8-K Current report
• 11.06.2025 - EX-99.1 EX-99.1
• 11.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.06.2025 - 8-K Current report
• 11.03.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 10.07.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.07.2025 - 3 Initial statement of beneficial ownership of securities
• 10.03.2025 - 8-K Current report
• 09.09.2025 - 8-K Current report